Onconetix, Inc. (ONCO)

Onconetix Statistics

Total Valuation

Onconetix has a market cap or net worth of $4.02 million. The enterprise value is $3.35 million.

Market Cap	4.02M
Enterprise Value	3.35M

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Onconetix has 1.56 million shares outstanding.

Current Share Class	1.56M
Shares Outstanding	1.56M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+150.88%
Owned by Insiders (%)	1.14%
Owned by Institutions (%)	6.31%
Float	1.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.20
Forward PS	n/a
PB Ratio	1.19
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.08, with a Debt / Equity ratio of 0.05.

Current Ratio	0.08
Quick Ratio	0.05
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.86

Financial Efficiency

Return on equity (ROE) is -221.37% and return on invested capital (ROIC) is -11.05%.

Return on Equity (ROE)	-221.37%
Return on Assets (ROA)	-7.41%
Return on Invested Capital (ROIC)	-11.05%
Return on Capital Employed (ROCE)	-143.24%
Revenue Per Employee	$244,750
Profits Per Employee	-$10.17M
Employee Count	5
Asset Turnover	0.03
Inventory Turnover	1.31

Taxes

Income Tax	-917,997
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.32% in the last 52 weeks. The beta is 3.42, so Onconetix's price volatility has been higher than the market average.

Beta (5Y)	3.42
52-Week Price Change	-95.32%
50-Day Moving Average	3.06
200-Day Moving Average	5.83
Relative Strength Index (RSI)	46.24
Average Volume (20 Days)	30,968

Short Selling Information

The latest short interest is 63,863, so 4.09% of the outstanding shares have been sold short.

Short Interest	63,863
Short Previous Month	125,367
Short % of Shares Out	4.09%
Short % of Float	5.08%
Short Ratio (days to cover)	2.24

Income Statement

In the last 12 months, Onconetix had revenue of $1.22 million and -$50.85 million in losses. Loss per share was -$89.08.

Revenue	1.22M
Gross Profit	1.05M
Operating Income	-4.84M
Pretax Income	-50.06M
Net Income	-50.85M
EBITDA	-4.70M
EBIT	-4.84M
Loss Per Share	-$89.08

Balance Sheet

The company has $836,556 in cash and $166,422 in debt, giving a net cash position of $670,134 or $0.43 per share.

Cash & Cash Equivalents	836,556
Total Debt	166,422
Net Cash	670,134
Net Cash Per Share	$0.43
Equity (Book Value)	3.37M
Book Value Per Share	2.16
Working Capital	-15.00M

Cash Flow

In the last 12 months, operating cash flow was -$7.51 million and capital expenditures -$3,874, giving a free cash flow of -$7.51 million.

Operating Cash Flow	-7.51M
Capital Expenditures	-3,874
Free Cash Flow	-7.51M
FCF Per Share	-$4.81

Margins

Gross Margin	85.41%
Operating Margin	-395.14%
Pretax Margin	-4,090.57%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Onconetix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-1,265.21%
FCF Yield	-186.86%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 13, 2025. It was a reverse split with a ratio of 1:85.

Last Split Date	Jun 13, 2025
Split Type	Reverse
Split Ratio	1:85

Scores

Onconetix has an Altman Z-Score of -11.12 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-11.12
Piotroski F-Score	3